WHO is set to resume its global trial of hydroxychloroquine
Written by Lethiwe Mdluli on 4 June, 2020
The World Health Organisation says that clinical trials of the drug hydroxychloroquine as a possible treatment for the coronavirus will be resumed.
Last month the organisation temporarily suspended trials of the malaria drug due to safety concerns.
More than 3500 patients in 35 countries have been recruited to take part in the trials.
WHO’s, Soumya Swaminathan, says there is currently no evidence that any medicine reduces the deaths of Covid-19 patients.
Listen here:
Podcast stream by Fabrik.fm
Meanwhile Doctors Without Borders has urged the Global Alliance for Vaccines and Immunizations, to ensure that any future Covid-19 vaccines are sold at a low cost and are accessible to all.
Gavi is holding its third donor pledging conference today.
Gavi plans to launch the COVAX facility, a global mechanism to negotiate with pharmaceutical corporations for the procurement of Covid-19 vaccines.
Doctors Without Borders’ Kate Elder, says any funds made available to pharmaceutical corporations must have strings attached.
Listen here:
Podcast stream by Fabrik.fm
By: Gagasi FM News
Continue reading
